Suppr超能文献

策略性地利用构象偏向和基于结构的设计来识别强效 JAK3 抑制剂,提高对 JAK 家族和激酶组的选择性。

Strategic use of conformational bias and structure based design to identify potent JAK3 inhibitors with improved selectivity against the JAK family and the kinome.

机构信息

Discovery Chemistry, Hoffmann-La Roche, pRED, Pharma Research & Early Development, 340 Kingsland Street, Nutley, NJ 07110, USA.

出版信息

Bioorg Med Chem Lett. 2013 May 1;23(9):2793-800. doi: 10.1016/j.bmcl.2013.02.012. Epub 2013 Feb 13.

Abstract

Using a structure based design approach we have identified a series of indazole substituted pyrrolopyrazines, which are potent inhibitors of JAK3. Intramolecular electronic repulsion was used as a strategy to induce a strong conformational bias within the ligand. Compounds bearing this conformation participated in a favorable hydrophobic interaction with a cysteine residue in the JAK3 binding pocket, which imparted high selectivity versus the kinome and improved selectivity within the JAK family.

摘要

我们采用基于结构的设计方法,鉴定了一系列吲唑取代的吡咯并吡嗪类化合物,它们是强效 JAK3 抑制剂。我们采用分子内电子排斥策略,在配体中诱导强烈的构象偏向。具有这种构象的化合物与 JAK3 结合口袋中的半胱氨酸残基发生有利的疏水相互作用,从而赋予其对激酶组的高选择性,并提高 JAK 家族内的选择性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验